{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T23:59:02Z","timestamp":1772236742251,"version":"3.50.1"},"reference-count":80,"publisher":"Bentham Science Publishers Ltd.","issue":"7","funder":[{"DOI":"10.13039\/100009145","name":"Botswana International University of Science and Technology","doi-asserted-by":"publisher","award":["R00024"],"award-info":[{"award-number":["R00024"]}],"id":[{"id":"10.13039\/100009145","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CSCR"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Treating diseases such as Muscular dystrophy (MD) and HIV\/AIDS pose several challenges\nto the rapidly evolving field of regenerative medicine. Previously, stem cell therapy has\nbeen said to affect the clinical courses of HIV\/AIDS and MD, but, in practice, eradication or control\nof these diseases was not achievable. The introduction of gene editing into stem cell therapy\nhas stimulated HIV\/AIDS and MD cell therapy research studies substantially. Here, we review current\nmethods of treating HIV\/AIDS and MD using stem cell therapy. This review also details the\nuse of different types of cells and methods in cell therapy and the modeling of new cell-based therapies\nto treat Duchenne muscular dystrophy. We speculate that the effective use of stem cell therapy\nin conjunction with other treatment therapies , such as steroids and rehabilitation , could improve\nlivelihood.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574888x16666210810104445","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T18:00:52Z","timestamp":1630951252000},"page":"633-647","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Application of Stem Cell Therapy During the Treatment of HIV\/AIDS and\nDuchenne Muscular Dystrophy"],"prefix":"10.2174","volume":"17","author":[{"given":"Goabaone","family":"Gaobotse","sequence":"first","affiliation":[{"name":"Department of Biological Sciences and Biotechnology, Botswana International University of Science and Technology,\nPrivate Bag 16, Palapye, Botswana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"Chitena","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences and Biotechnology, Botswana International University of Science and Technology,\nPrivate Bag 16, Palapye, Botswana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keletso","family":"Masisi","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences and Biotechnology, Botswana International University of Science and Technology,\nPrivate Bag 16, Palapye, Botswana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kabo","family":"Masisi","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences and Biotechnology, Botswana International University of Science and Technology,\nPrivate Bag 16, Palapye, Botswana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tebogo E.","family":"Kwape","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences and Biotechnology, Botswana International University of Science and Technology,\nPrivate Bag 16, Palapye, Botswana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e1007958","DOI":"10.1371\/journal.ppat.1007958","volume":"15","author":"Rodr\u00edguez-Mora S.","year":"2019","unstructured":"Rodr\u00edguez-Mora S.; De Wit F.; Garc\u00eda-Perez J.; Bermejo M.; L\u00f3pez-Huertas M.R.; Mateos E.; Mart\u00ed P.; Rocha S.; Vig\u00f3n L.; Christ F.; Debyser Z.; V\u00edlchez J.J.; Coiras M.; Alcam\u00ed J.; The mutation of Transportin 3 gene that causes limb girdle muscular dystrophy 1F induces protection against HIV-1 infection. PLoS Pathog 2019,15(8),e1007958","journal-title":"PLoS Pathog"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13023-020-01430-8","volume":"15","author":"Crisafulli S.","year":"2020","unstructured":"Crisafulli S.; Sultana J.; Fontana A.; Salvo F.; Messina S.; Trifir\u00f2 G.; Global epidemiology of Duchenne muscular dystrophy: An updated systematic review and meta-analysis. Orphanet J Rare Dis 2020,15(1),141","journal-title":"Orphanet J Rare Dis"},{"key":"ref=3","year":"2019","unstructured":"Global HIV and AIDS statistics-2019 fact sheet. UNAIDSAvailable from:\n. (Accessed on: February 17, 2020).2019"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fcimb.2019.00069","volume":"9","author":"Xiao Q.","year":"2019","unstructured":"Xiao Q.; Guo D.; Chen S.; Application of CRISPR\/Cas9-based gene editing in HIV-1\/AIDS therapy. Front Cell Infect Microbiol 2019,9(69),69","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12981-016-0114-y","volume":"13","author":"H\u00fctter G.","year":"2016","unstructured":"H\u00fctter G.; Stem cell transplantation in strategies for curing HIV\/AIDS. AIDS Res Ther 2016,13(1),31","journal-title":"AIDS Res Ther"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.3390\/v7082816","volume":"7","author":"H\u00fctter G.","year":"2015","unstructured":"H\u00fctter G.; Bodor J.; Ledger S.; Boyd M.; Millington M.; Tsie M.; Symonds G.; CCR5 targeted cell therapy for HIV and prevention of viral escape. Viruses 2015,7(8),4186-4203","journal-title":"Viruses"},{"key":"ref=7","first-page":"167","volume":"19","author":"Soriano V.","year":"2017","unstructured":"Soriano V.; Hot news: Gene therapy with CRISPR\/Cas9 coming to age for HIV cure. AIDS Rev 2017,19(3),167-172","journal-title":"AIDS Rev"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","volume":"568","author":"Gupta R.K.","year":"2019","unstructured":"Gupta R.K.; Abdul-Jawad S.; McCoy L.E.; Mok H.P.; Peppa D.; Salgado M.; Martinez-Picado J.; Nijhuis M.; Wensing A.M.J.; Lee H.; Grant P.; Nastouli E.; Lambert J.; Pace M.; Salasc F.; Monit C.; Innes A.J.; Muir L.; Waters L.; Frater J.; Lever A.M.L.; Edwards S.G.; Gabriel I.H.; Olavarria E.; HIV-1 remission following CCR5\u039432\/\u039432 haematopoietic stem-cell transplantation. Nature 2019,568(7751),244-248","journal-title":"Nature"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"11461","DOI":"10.1073\/pnas.1405186111","volume":"111","author":"Hu W.","year":"2014","unstructured":"Hu W.; Kaminski R.; Yang F.; Zhang Y.; Cosentino L.; Li F.; Luo B.; Alvarez-Carbonell D.; Garcia-Mesa Y.; Karn J.; Mo X.; Khalili K.; RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proc Natl Acad Sci 2014,111(31),11461-11466","journal-title":"Proc Natl Acad Sci"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e1002649","DOI":"10.1371\/journal.ppat.1002649","volume":"8","author":"Kitchen S.G.","year":"2012","unstructured":"Kitchen S.G.; Levin B.R.; Bristol G.; Rezek V.; Kim S.; Aguilera-Sandoval C.; Balamurugan A.; Yang O.O.; Zack J.A.; \nIn vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells. PLoS Pathog 2012,8(4),e1002649","journal-title":"PLoS Pathog"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1089\/apc.2016.0233","volume":"30","author":"Wang C.X.","year":"2016","unstructured":"Wang C.X.; Cannon P.M.; Clinical applications of genome editing to HIV cure. AIDS Patient Care STDS 2016,30(12),539-544","journal-title":"AIDS Patient Care STDS"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1542\/peds.2014-2044","volume":"135","author":"Romitti P.A.","year":"2015","unstructured":"Romitti P.A.; Zhu Y.; Puzhankara S.; James K.A.; Nabukera S.K.; Zamba G.K.; Ciafaloni E.; Cunniff C.; Druschel C.M.; Mathews K.D.; Matthews D.J.; Meaney F.J.; Andrews J.G.; Conway K.M.; Fox D.J.; Street N.; Adams M.M.; Bolen J.; Prevalence of duchenne and becker muscular dystrophies in the united states. Pediatrics 2015,135(3),513-521","journal-title":"Pediatrics"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/jpm8040038","volume":"8","author":"Lim K.R.Q.","year":"2018","unstructured":"Lim K.R.Q.; Yoon C.; Yokota T.; Applications of CRISPR\/Cas9 for the treatment of Duchenne muscular dystrophy. J Pers Med 2018,8(4),38-44","journal-title":"J Pers Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jpeds.2012.03.020","volume":"161","author":"Pane M.","year":"2012","unstructured":"Pane M.; Lombardo M.E.; Alfieri P.; D\u2019Amico A.; Bianco F.; Vasco G.; Piccini G.; Mallardi M.; Romeo D.M.; Ricotti V.; Ferlini A.; Gualandi F.; Vicari S.; Bertini E.; Berardinelli A.; Mercuri E.; Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: Phenotype-genotype correlation. J Pediatr 2012,161(4),705-9.e1","journal-title":"J Pediatr"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.nmd.2013.02.012","volume":"23","author":"Pane M.","year":"2013","unstructured":"Pane M.; Scalise R.; Berardinelli A.; D\u2019Angelo G.; Ricotti V.; Alfieri P.; Moroni I.; Hartley L.; Pera M.C.; Baranello G.; Catteruccia M.; Casalino T.; Romeo D.M.; Graziano A.; Gandioli C.; Bianco F.; Mazzone E.S.; Lombardo M.E.; Scoto M.; Sivo S.; Palermo C.; Gualandi F.; Sormani M.P.; Ferlini A.; Bertini E.; Muntoni F.; Mercuri E.; Early neurodevelopmental assessment in Duchenne muscular dystrophy. Neuromuscul Disord 2013,23(6),451-455","journal-title":"Neuromuscul Disord"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cell.2010.11.039","volume":"143","author":"Sacco A.","year":"2010","unstructured":"Sacco A.; Mourkioti F.; Tran R.; Choi J.; Llewellyn M.; Kraft P.; Shkreli M.; Delp S.; Pomerantz J.H.; Artandi S.E.; Blau H.M.; Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx\/mTR mice. Cell 2010,143(7),1059-1071","journal-title":"Cell"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physrev.00007.2015","volume":"96","author":"Allen D.G.","year":"2016","unstructured":"Allen D.G.; Whitehead N.P.; Froehner S.C.; Absence of Dystrophin disrupts skeletal muscle signalling: Roles of Ca, reactive oxygen species, and nitric oxide in the development of Muscular dystrophy. Physiol Rev 2016,96(1),253-305","journal-title":"Physiol Rev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3389\/fneur.2018.00368","volume":"9","author":"Andr\u00e9 L.M.","year":"2018","unstructured":"Andr\u00e9 L.M.; Ausems C.R.M.; Wansink D.G.; Wieringa B.; Abnormalities in skeletal muscle myogenesis, growth, and regeneration in myotonic dystrophy. Front Neurol 2018,9,368","journal-title":"Front Neurol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4330\/wjc.v7.i7.410","volume":"7","author":"Mavrogeni S.","year":"2015","unstructured":"Mavrogeni S.; Markousis-Mavrogenis G.; Papavasiliou A.; Kolovou G.; Cardiac involvement in Duchenne and Becker muscular dystrophy. World J Cardiol 2015,7(7),410-414","journal-title":"World J Cardiol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1172\/JCI40373","volume":"120","author":"Tedesco F.S.","year":"2010","unstructured":"Tedesco F.S.; Dellavalle A.; Diaz-Manera J.; Messina G.; Cossu G.; Repairing skeletal muscle: Regenerative potential of skeletal muscle stem cells. J Clin Invest 2010,120(1),11-19","journal-title":"J Clin Invest"},{"key":"ref=21","first-page":"771","volume":"14","author":"Inchingolo F.","year":"2010","unstructured":"Inchingolo F.; Tatullo M.; Marrelli M.; Inchingolo A.M.; Picciariello V.; Inchingolo A.D.; Dipalma G.; Vermesan D.; Cagiano R.; Clinical trial with bromelain in third molar exodontia. Eur Rev Med Pharmacol Sci 2010,14(9),771-774","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=22","first-page":"1222","volume":"16","author":"Inchingolo F.","year":"2012","unstructured":"Inchingolo F.; Tatullo M.; Marrelli M.; Inchingolo A.M.; Inchingolo A.D.; Dipalma G.; Flace P.; Girolamo F.; Tarullo A.; Laino L.; Sabatini R.; Abbinante A.; Cagiano R.; Regenerative surgery performed with platelet-rich plasma used in sinus lift elevation before dental implant surgery: An useful aid in healing and regeneration of bone tissue. Eur Rev Med Pharmacol Sci 2012,16(9),1222-1226","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/mus.23738","volume":"47","author":"Konieczny P.","year":"2013","unstructured":"Konieczny P.; Swiderski K.; Chamberlain J.S.; Gene and cell-mediated therapies for muscular dystrophy. Muscle Nerve 2013,47(5),649-663","journal-title":"Muscle Nerve"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/COH.0000000000000106","volume":"9","author":"Meulendyke K.A.","year":"2014","unstructured":"Meulendyke K.A.; Croteau J.D.; Zink M.C.; HIV life cycle, innate immunity and autophagy in the central nervous system. Curr Opin HIV AIDS 2014,9(6),565-571","journal-title":"Curr Opin HIV AIDS"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e1000384","DOI":"10.1371\/journal.ppat.1000384","volume":"5","author":"Freer G.","year":"2009","unstructured":"Freer G.; Matteucci D.; Influence of dendritic cells on viral pathogenicity. PLoS Pathog 2009,5(7),e1000384","journal-title":"PLoS Pathog"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.it.2013.10.003","volume":"35","author":"Manches O.","year":"2014","unstructured":"Manches O.; Frleta D.; Bhardwaj N.; Dendritic cells in progression and pathology of HIV infection. Trends Immunol 2014,35(3),114-122","journal-title":"Trends Immunol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/gt.2013.70","volume":"21","author":"Falkenhagen A.","year":"2014","unstructured":"Falkenhagen A.; Ameli M.; Asad S.; Read S.E.; Joshi S.; A novel gene therapy strategy using secreted multifunctional anti-HIV proteins to confer protection to gene-modified and unmodified target cells. Gene Ther 2014,21(2),175-187","journal-title":"Gene Ther"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev.immunol.18.1.665","volume":"18","author":"Pierson T.","year":"2000","unstructured":"Pierson T.; McArthur J.; Siliciano R.F.; Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol 2000,18(1),665-708","journal-title":"Annu Rev Immunol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-4690-1-9","volume":"1","author":"Nisole S.","year":"2004","unstructured":"Nisole S.; Sa\u00efb A.; Early steps of retrovirus replicative cycle. Retrovirology 2004,1,9-14","journal-title":"Retrovirology"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e1003161","DOI":"10.1371\/journal.ppat.1003161","volume":"9","author":"Mohammadi P.","year":"2013","unstructured":"Mohammadi P.; Desfarges S.; Bartha I.; Joos B.; Zangger N.; Mu\u00f1oz M.; G\u00fcnthard H.F.; Beerenwinkel N.; Telenti A.; Ciuffi A.; 24 hours in the life of HIV-1 in a T cell line. PLoS Pathog 2013,9(1),e1003161","journal-title":"PLoS Pathog"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/HIV.S141965","volume":"10","author":"Dubrocq G.","year":"2018","unstructured":"Dubrocq G.; Rakhmanina N.; Antiretroviral therapy interruptions: Impact on HIV treatment and transmission. HIV AIDS 2018,10,91-101","journal-title":"HIV AIDS"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"a007161","DOI":"10.1101\/cshperspect.a007161","volume":"2","author":"Arts E.J.","year":"2012","unstructured":"Arts E.J.; Hazuda D.J.; HIV-1 antiretroviral drug therapy. Cold Spring Harb Perspect Med 2012,2(4),a007161","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.actatropica.2004.11.006","volume":"93","author":"Pai H.H.","year":"2005","unstructured":"Pai H.H.; Chen W.C.; Peng C.F.; Isolation of bacteria with antibiotic resistance from household cockroaches (Periplaneta americana and Blattella germanica). Acta Trop 2005,93(3),259-265","journal-title":"Acta Trop"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.idc.2014.06.001","volume":"28","author":"Pau A.K.","year":"2014","unstructured":"Pau A.K.; George J.M.; Antiretroviral therapy: Current drugs. Infect Dis Clin North Am 2014,28(3),371-402","journal-title":"Infect Dis Clin North Am"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aaz2686","volume":"11","author":"Haynes B.F.","year":"2019","unstructured":"Haynes B.F.; Burton D.R.; Mascola J.R.; Multiple roles for HIV broadly neutralizing antibodies. Sci Transl Med 2019,11(516),1-4","journal-title":"Sci Transl Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.antiviral.2009.10.016","volume":"85","author":"Hawkins T.","year":"2010","unstructured":"Hawkins T.; Understanding and managing the adverse effects of antiretroviral therapy. Antiviral Res 2010,85(1),201-209","journal-title":"Antiviral Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/nbt1367","volume":"25","author":"Rossi J.J.","year":"2007","unstructured":"Rossi J.J.; June C.H.; Kohn D.B.; Genetic therapies against HIV. Nat Biotechnol 2007,25(12),1444-1454","journal-title":"Nat Biotechnol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.omtn.2018.09.018","volume":"13","author":"Falkenhagen A.","year":"2018","unstructured":"Falkenhagen A.; Joshi S.; Genetic Strategies for HIV treatment and prevention. Mol Ther Nucleic Acids 2018,13,514-533","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.addr.2016.04.027","volume":"103","author":"Pernet O.","year":"2016","unstructured":"Pernet O.; Yadav S.S.; An D.S.; Stem cell-based therapies for HIV\/AIDS. Adv Drug Deliv Rev 2016,103,187-201","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4103\/0253-7613.96296","volume":"44","author":"Desai M.","year":"2012","unstructured":"Desai M.; Iyer G.; Dikshit R.K.; Antiretroviral drugs: Critical issues and recent advances. Indian J Pharmacol 2012,44(3),288-298","journal-title":"Indian J Pharmacol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2325-9620.1000142","volume":"7","author":"Gaobotse G.","year":"2018","unstructured":"Gaobotse G.; Stem cell research in Africa: Legislation","journal-title":"J Regen Med"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/jcbfm.2009.1","volume":"29","author":"Liu Y.P.","year":"2009","unstructured":"Liu Y.P.; Se\u00e7kin H.; Izci Y.; Du Z.W.; Yan Y.P.; Ba\u015fkaya M.K.; Neuroprotective effects of mesenchymal stem cells derived from human embryonic stem cells in transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2009,29(4),780-791","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"833","DOI":"10.5966\/sctm.2012-0071","volume":"1","author":"Wilschut K.J.","year":"2012","unstructured":"Wilschut K.J.; Ling V.B.; Bernstein H.S.; Bernstein H.S.; Concise review: Stem cell therapy for muscular dystrophies. Stem Cells Transl Med 2012,1(11),833-842","journal-title":"Stem Cells Transl Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1083\/jcb.200112106","volume":"157","author":"Tamaki T.","year":"2002","unstructured":"Tamaki T.; Akatsuka A.; Ando K.; Nakamura Y.; Matsuzawa H.; Hotta T.; Roy R.R.; Edgerton V.R.; Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol 2002,157(4),571-577","journal-title":"J Cell Biol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.stem.2012.02.015","volume":"10","author":"Darabi R.","year":"2012","unstructured":"Darabi R.; Arpke R.W.; Irion S.; Dimos J.T.; Grskovic M.; Kyba M.; Perlingeiro R.C.; Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell 2012,10(5),610-619","journal-title":"Cell Stem Cell"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1083\/jcb.200202092","volume":"159","author":"Asakura A.","year":"2002","unstructured":"Asakura A.; Seale P.; Girgis-Gabardo A.; Rudnicki M.A.; Myogenic specification of side population cells in skeletal muscle. J Cell Biol 2002,159(1),123-134","journal-title":"J Cell Biol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/sj.gt.3302521","volume":"12","author":"Payne T.R.","year":"2005","unstructured":"Payne T.R.; Oshima H.; Sakai T.; Ling Y.; Gharaibeh B.; Cummins J.; Huard J.; Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells. Gene Ther 2005,12(16),1264-1274","journal-title":"Gene Ther"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/1756285615586123","volume":"8","author":"Sienkiewicz D.","year":"2015","unstructured":"Sienkiewicz D.; Kulak W.; Okurowska-Zawada B.; Paszko-Patej G.; Kawnik K.; Duchenne muscular dystrophy: Current cell therapies. Ther Adv Neurol Disorder 2015,8(4),166-177","journal-title":"Ther Adv Neurol Disorder"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.3727\/096368913X672136","volume":"22","author":"Sharma A.","year":"2013","unstructured":"Sharma A.; Sane H.; Badhe P.; Gokulchandran N.; Kulkarni P.; Lohiya M.; Biju H.; Jacob V.C.; A clinical study shows safety and efficacy of autologous bone marrow mononuclear cell therapy to improve quality of life in muscular dystrophy patients. Cell Transplant 2013,22(1),S127-S138","journal-title":"Cell Transplant"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"282348","DOI":"10.1155\/2012\/282348","volume":"2012","author":"Maclean S.","year":"2012","unstructured":"Maclean S.; Khan W.S.; Malik A.A.; Anand S.; Snow M.; The potential of stem cells in the treatment of skeletal muscle injury and disease. Stem Cells Int 2012,2012,282348","journal-title":"Stem Cells Int"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cellimm.2009.10.006","volume":"260","author":"Ichim T.E.","year":"2010","unstructured":"Ichim T.E.; Alexandrescu D.T.; Solano F.; Lara F.; Campion Rde.N.; Paris E.; Woods E.J.; Murphy M.P.; Dasanu C.A.; Patel A.N.; Marleau A.M.; Leal A.; Riordan N.H.; Mesenchymal stem cells as anti-inflammatories: Implications for treatment of Duchenne muscular dystrophy. Cell Immunol 2010,260(2),75-82","journal-title":"Cell Immunol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/cells7120253","volume":"7","author":"Danisovic L.","year":"2018","unstructured":"Danisovic L.; Culenova M.; Csobonyeiova M.; Induced pluripotent stem cells for Duchenne muscular dystrophy modelling and therapy. Cells 2018,7(12),253-264","journal-title":"Cells"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1126\/science.1162494","volume":"322","author":"Stadtfeld M.","year":"2008","unstructured":"Stadtfeld M.; Nagaya M.; Utikal J.; Weir G.; Hochedlinger K.; Induced pluripotent stem cells generated without viral integration. Science 2008,322(5903),945-949","journal-title":"Science"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.tibtech.2020.03.006","volume":"38","author":"Polanco A.","year":"2020","unstructured":"Polanco A.; Kuang B.; Yoon S.; Bioprocess technologies that preserve the quality of ipscs. Trends Biotechnol 2020,38(10),1128-1140","journal-title":"Trends Biotechnol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s12265-008-9032-2","volume":"1","author":"Pappas J.J.","year":"2008","unstructured":"Pappas J.J.; Yang P.C.; Human ESC vs. iPSC-pros and cons. J Cardiovasc Transl Res 2008,1(2),96-99","journal-title":"J Cardiovasc Transl Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1574888X09666140923101914","volume":"10","author":"Deng X.Y.","year":"2015","unstructured":"Deng X.Y.; Wang H.; Wang T.; Fang X.T.; Zou L.L.; Li Z.Y.; Liu C.B.; Non-viral methods for generating integration-free, induced pluripotent stem cells. Curr Stem Cell Res Ther 2015,10(2),153-158","journal-title":"Curr Stem Cell Res Ther"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13287-019-1185-1","volume":"10","author":"Gorecka J.","year":"2019","unstructured":"Gorecka J.; Kostiuk V.; Fereydooni A.; Gonzalez L.; Luo J.; Dash B.; Isaji T.; Ono S.; Liu S.; Lee S.R.; Xu J.; Liu J.; Taniguchi R.; Yastula B.; Hsia H.C.; Qyang Y.; Dardik A.; The potential and limitations of induced pluripotent stem cells to achieve wound healing. Stem Cell Res Ther 2019,10(1),87-96","journal-title":"Stem Cell Res Ther"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"Yu J.","year":"2007","unstructured":"Yu J.; Vodyanik M.A.; Smuga-Otto K.; Antosiewicz-Bourget J.; Frane J.L.; Tian S.; Nie J.; Jonsdottir G.A.; Ruotti V.; Stewart R.; Slukvin I.I.; Thomson J.A.; Induced pluripotent stem cell lines derived from human somatic cells. Science 2007,318(5858),1917-1920","journal-title":"Science"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fcell.2015.00002","volume":"3","author":"Singh V.K.","year":"2015","unstructured":"Singh V.K.; Kalsan M.; Kumar N.; Saini A.; Chandra R.; Induced pluripotent stem cells: Applications in regenerative medicine, disease modeling, and drug discovery. Front Cell Dev Biol 2015,3,2","journal-title":"Front Cell Dev Biol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-1-62703-348-0_3","volume":"997","author":"Malik N.","year":"2013","unstructured":"Malik N.; Rao M.S.; A review of the methods for human iPSC derivation. Methods Mol Biol 2013,997,23-33","journal-title":"Methods Mol Biol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/ma12040597","volume":"12","author":"Tatullo M.","year":"2019","unstructured":"Tatullo M.; Spagnuolo G.; Codispoti B.; Zamparini F.; Zhang A.; Esposti M.D.; Aparicio C.; Rengo C.; Nuzzolese M.; Manzoli L.; Fava F.; Prati C.; Fabbri P.; Gandolfi M.G.; PLA-based mineral-doped scaffolds seeded with human periapical cyst-derived mscs: A promising tool for regenerative healing in dentistry. Materials 2019,12(4),597","journal-title":"Materials"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3389\/fphys.2018.01685","volume":"9","author":"Marrelli M.","year":"2018","unstructured":"Marrelli M.; Codispoti B.; Shelton R.M.; Scheven B.A.; Cooper P.R.; Tatullo M.; Paduano F.; Dental pulp stem cell mechanoresponsiveness: Effects of mechanical stimuli on dental pulp stem cell behavior. Front Physiol 2018,9,1685-1691","journal-title":"Front Physiol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s12257-009-0102-3","volume":"15","author":"Han M-J.","year":"2010","unstructured":"Han M-J.; Seo Y-K.; Yoon H-H.; Song K-Y.; Park J-K.; Upregulation of bone-like extracellular matrix expression in human dental pulp stem cells by mechanical strain. Biotechnol Bioprocess Eng; BBE 2010,15,572-579","journal-title":"Biotechnol Bioprocess Eng; BBE"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1089\/ten.tea.2012.0099","volume":"19","author":"Hata M.","year":"2013","unstructured":"Hata M.; Naruse K.; Ozawa S.; Kobayashi Y.; Nakamura N.; Kojima N.; Omi M.; Katanosaka Y.; Nishikawa T.; Naruse K.; Tanaka Y.; Matsubara T.; Mechanical stretch increases the proliferation while inhibiting the osteogenic differentiation in dental pulp stem cells. Tissue Eng Part A 2013,19(5-6),625-633","journal-title":"Tissue Eng Part A"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"6975251","DOI":"10.1155\/2017\/6975251","volume":"2017","author":"Ballini A.","year":"2017","unstructured":"Ballini A.; Boccaccio A.; Saini R.; Van Pham P.; Tatullo M.; Dental-derived stem cells and their secretome and interactions with bioscaffolds\/biomaterials in regenerative medicine: From the in vitro research to translational applications. Stem Cells Int 2017,2017,6975251","journal-title":"Stem Cells Int"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/0963689792001002-305","volume":"1","author":"Law P.K.","year":"1992","unstructured":"Law P.K.; Goodwin T.G.; Fang Q.; Duggirala V.; Larkin C.; Florendo J.A.; Kirby D.S.; Deering M.B.; Li H.J.; Chen M.; Yo T.J.; Cornett J.; Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys. Cell Transplant 1992,1(2-3),235-244","journal-title":"Cell Transplant"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/356435a0","volume":"356","author":"Gussoni E.","year":"1992","unstructured":"Gussoni E.; Pavlath G.K.; Lanctot A.M.; Sharma K.R.; Miller R.G.; Steinman L.; Blau H.M.; Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 1992,356(6368),435-438","journal-title":"Nature"},{"key":"ref=68","author":"Sharma A.","year":"2016","unstructured":"Sharma A.; Badhe P.; Sane H.; Gokulchandran N.; Paranjape A.; Role of stem cell therapy in treatment of muscular dystrophy. Available from: 2016"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/jnnp.36.3.399","volume":"36","author":"Dastur D.K.","year":"1973","unstructured":"Dastur D.K.; Razzak Z.A.; Possible neurogenic factor in muscular dystrophy: Its similarity to denervation atrophy. J Neurol Neurosurg Psychiatry 1973,36(3),399-410","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/mt.2009.274","volume":"18","author":"Kazuki Y.","year":"2010","unstructured":"Kazuki Y.; Hiratsuka M.; Takiguchi M.; Osaki M.; Kajitani N.; Hoshiya H.; Hiramatsu K.; Yoshino T.; Kazuki K.; Ishihara C.; Takehara S.; Higaki K.; Nakagawa M.; Takahashi K.; Yamanaka S.; Oshimura M.; Complete genetic correction of ips cells from Duchenne muscular dystrophy. Mol Ther 2010,18(2),386-393","journal-title":"Mol Ther"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ana.24555","volume":"79","author":"Mendell J.R.","year":"2016","unstructured":"Mendell J.R.; Goemans N.; Lowes L.P.; Alfano L.N.; Berry K.; Shao J.; Kaye E.M.; Mercuri E.; Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy. Ann Neurol 2016,79(2),257-271","journal-title":"Ann Neurol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"e1914171","DOI":"10.1001\/jamanetworkopen.2019.14171","volume":"2","author":"Hafner P.","year":"2019","unstructured":"Hafner P.; Bonati U.; Klein A.; Rubino D.; Gocheva V.; Schmidt S.; Schroeder J.; Bernert G.; Laugel V.; Steinlin M.; Capone A.; Gloor M.; Bieri O.; Hemkens L.G.; Speich B.; Zumbrunn T.; Gueven N.; Fischer D.; Effect of combination l-citrulline and metformin treatment on motor function in patients with duchenne muscular dystrophy: A randomized clinical trial. JAMA Netw Open 2019,2(10),e1914171","journal-title":"JAMA Netw Open"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","volume":"18","author":"Young C.S.","year":"2016","unstructured":"Young C.S.; Hicks M.R.; Ermolova N.V.; Nakano H.; Jan M.; Younesi S.; Karumbayaram S.; Kumagai-Cresse C.; Wang D.; Zack J.A.; Kohn D.B.; Nakano A.; Nelson S.F.; Miceli M.C.; Spencer M.J.; Pyle A.D.; A single crispr-cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells. Cell Stem Cell 2016,18(4),533-540","journal-title":"Cell Stem Cell"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s12015-018-9807-z","volume":"14","author":"Siemionow M.","year":"2018","unstructured":"Siemionow M.; Cwykiel J.; Heydemann A.; Garcia J.; Marchese E.; Siemionow K.; Szilagyi E.; Dystrophin expressing chimeric (DEC) human cells provide a potential therapy for Duchenne muscular dystrophy. Stem Cell Rev Rep 2018,14(3),370-384","journal-title":"Stem Cell Rev Rep"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1111\/j.1572-0241.2008.01993.x","volume":"103","author":"Pai M.","year":"2008","unstructured":"Pai M.; Zacharoulis D.; Milicevic M.N.; Helmy S.; Jiao L.R.; Levicar N.; Tait P.; Scott M.; Marley S.B.; Jestice K.; Glibetic M.; Bansi D.; Khan S.A.; Kyriakou D.; Rountas C.; Thillainayagam A.; Nicholls J.P.; Jensen S.; Apperley J.F.; Gordon M.Y.; Habib N.A.; Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 2008,103(8),1952-1958","journal-title":"Am J Gastroenterol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1634\/stemcells.2005-0542","volume":"24","author":"Terai S.","year":"2006","unstructured":"Terai S.; Ishikawa T.; Omori K.; Aoyama K.; Marumoto Y.; Urata Y.; Yokoyama Y.; Uchida K.; Yamasaki T.; Fujii Y.; Okita K.; Sakaida I.; Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006,24(10),2292-2298","journal-title":"Stem Cells"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/CIRCINTERVENTIONS.113.001009","volume":"7","author":"de Jong R.","year":"2014","unstructured":"de Jong R.; Houtgraaf J.H.; Samiei S.; Boersma E.; Duckers H.J.; Intracoronary stem cell infusion after acute myocardial infarction: A meta-analysis and update on clinical trials. Circ Cardiovasc Interv 2014,7(2),156-167","journal-title":"Circ Cardiovasc Interv"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/scrt459","volume":"5","author":"Salama H.","year":"2014","unstructured":"Salama H.; Zekri A-R.N.; Medhat E.; Al Alim S.A.; Ahmed O.S.; Bahnassy A.A.; Lotfy M.M.; Ahmed R.; Musa S.; Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease. Stem Cell Res Ther 2014,5(3),70-77","journal-title":"Stem Cell Res Ther"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/sctm.18-0031","volume":"7","author":"Park E.H.","year":"2018","unstructured":"Park E.H.; Lim H.S.; Lee S.; Roh K.; Seo K-W.; Kang K-S.; Shin K.; Intravenous infusion of umbilical cord blood-derived mesenchymal stem cells in rheumatoid arthritis: A phase Ia clinical trial. Stem Cells Transl Med 2018,7(9),636-642","journal-title":"Stem Cells Transl Med"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/s41409-019-0674-2","volume":"55","author":"Lin Q.","year":"2020","unstructured":"Lin Q.; Liu X.; Han L.; Liu L.; Fang B.; Gao Q.; Song Y.; Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA-CAR-T therapy in patient with relapsed myeloma. Bone Marrow Transplant 2020,55(6),1203-1205","journal-title":"Bone Marrow Transplant"}],"container-title":["Current Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574888X16666210810104445","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/195479\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574888X16666210810104445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T06:15:19Z","timestamp":1663395319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/195479\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574888x16666210810104445","relation":{},"ISSN":["1574-888X"],"issn-type":[{"value":"1574-888X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-02-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}